Biotech entity

NHS Scotland

organization

All 1 tracked stories fall under one category: pharma. Novartis is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention NHS Scotland, all published on March 23, 2026.

Last mentioned: Mar 23, 2026

Entity pulse

Recent coverage · NHS Scotland

1 story
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about NHS Scotland

All 1 tracked stories fall under one category: pharma. Novartis is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention NHS Scotland, all published on March 23, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 11 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering NHS Scotland. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Data Review

    Expected first quarterly report on screening uptake and identification rates in Scotland.

  2. Scotland Launch

    Scotland officially begins nationwide screening for all newborns.

  3. UK NSC Recommendation

    The UK National Screening Committee begins formal review of SMA for the newborn panel.

  4. Zolgensma UK Approval

    NHS England and Scotland reach deals to fund the world's most expensive gene therapy.

Stories mentioning NHS Scotland 1

Pharma Positive

Scotland Becomes First UK Nation to Launch Newborn SMA Screening Program

Scotland has officially become the first nation in the United Kingdom to implement routine newborn screening for Spinal Muscular Atrophy (SMA). This landmark public health initiative aims to identify the rare genetic condition within days of birth, enabling immediate access to life-saving gene therapies before irreversible muscle wasting occurs.

2 sources

NHS Scotland is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.